Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 20, 2023

SELL
$0.49 - $0.82 $2,205 - $3,690
-4,500 Reduced 0.38%
1,164,500 $640,000
Q1 2023

Apr 20, 2023

BUY
$0.65 - $1.1 $212,875 - $360,250
327,500 Added 38.92%
1,169,000 $959,000
Q3 2022

Oct 25, 2022

BUY
$0.79 - $22.0 $32,785 - $913,000
41,500 Added 5.19%
841,500 $724,000
Q2 2022

Jul 15, 2022

BUY
$0.8 - $1.5 $65,800 - $123,375
82,250 Added 11.46%
800,000 $672,000
Q1 2022

Apr 13, 2022

BUY
$1.24 - $2.75 $8,990 - $19,937
7,250 Added 1.02%
717,750 $976,000
Q4 2021

Jan 21, 2022

BUY
$2.42 - $3.65 $38,720 - $58,400
16,000 Added 2.3%
710,500 $1.78 Million
Q3 2021

Oct 29, 2021

BUY
$2.82 - $3.7 $112,659 - $147,815
39,950 Added 6.1%
694,500 $2.24 Million
Q2 2021

Jul 16, 2021

BUY
$3.5 - $5.48 $279,125 - $437,030
79,750 Added 13.87%
654,550 $2.34 Million
Q1 2021

May 05, 2021

BUY
$3.16 - $4.89 $51,508 - $79,707
16,300 Added 2.92%
574,800 $2.03 Million
Q4 2020

Feb 03, 2021

BUY
$2.2 - $4.45 $227,150 - $459,462
103,250 Added 22.68%
558,500 $1.77 Million
Q3 2020

Oct 28, 2020

BUY
$2.62 - $4.78 $287,545 - $524,605
109,750 Added 31.77%
455,250 $1.84 Million
Q2 2020

Aug 20, 2020

BUY
$1.83 - $3.16 $18,300 - $31,600
10,000 Added 2.98%
345,500 $926,000
Q1 2020

May 01, 2020

BUY
$1.14 - $2.96 $27,359 - $71,040
24,000 Added 7.7%
335,500 $634,000
Q4 2019

Jan 28, 2020

BUY
$1.25 - $2.57 $167,500 - $344,380
134,000 Added 75.49%
311,500 $801,000
Q3 2019

Oct 29, 2019

BUY
$1.26 - $1.96 $182,574 - $284,004
144,900 Added 444.48%
177,500 $250,000
Q4 2018

Feb 01, 2019

BUY
$0.57 - $1.53 $11,399 - $30,600
20,000 Added 158.73%
32,600 $28,000
Q3 2018

Nov 05, 2018

BUY
$1.44 - $3.13 $18,144 - $39,438
12,600 New
12,600 $20,000

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $194M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Shikiar Asset Management Inc Portfolio

Follow Shikiar Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shikiar Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Shikiar Asset Management Inc with notifications on news.